Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Next-generation Sequencing03:00

Next-generation Sequencing

99.2K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
99.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Cancer Therapies02:49

Cancer Therapies

10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

9.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetically proxied inhibition of cholesterol-lowering drug targets and survival in HPV-positive and non-HPV driven head and neck cancer: a multicentre MR study.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Equitable Health Intelligence: An Open Benchmark of Multi-Population Machine Learning for Omics-Based Cancer Prognosis.

bioRxiv : the preprint server for biology·2026
Same author

Quantum ensembling methods for healthcare and life science.

Briefings in bioinformatics·2026
Same author

Survival and Quality of Life After Reirradiation With Concurrent Pemetrexed/Erlotinib Followed by Maintenance Erlotinib for Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma: Final Report of a Phase I/II Trial.

Cureus·2026
Same author

RAS signaling in lung adenocarcinoma is defined by lineage context and DUSP4 loss.

JCI insight·2026
Same author

Inactivation of CDKN2AARF Promotes p53-Independent Remodeling of the PDAC Tumor Microenvironment.

Cancer research·2026

Related Experiment Video

Updated: Feb 18, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.3K

Enhancing Next-Generation Sequencing-Guided Cancer Care Through Cognitive Computing.

Nirali M Patel1,2, Vanessa V Michelini3, Jeff M Snell1,4

  • 1Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

The Oncologist
|November 22, 2017
PubMed
Summary
This summary is machine-generated.

Cognitive computing with Watson for Genomics (WfG) identified more actionable genomic events for cancer patients than human molecular tumor boards (MTBs). This AI-powered approach offers faster, comprehensive analysis for precision medicine and clinical trial matching.

Keywords:
Artificial intelligenceGenomicsHigh‐throughput nucleotide sequencingPrecision medicine

More Related Videos

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

442
Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

20.0K

Related Experiment Videos

Last Updated: Feb 18, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.3K
Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

442
Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

20.0K

Area of Science:

  • Oncology
  • Genomics
  • Bioinformatics

Background:

  • Next-generation sequencing (NGS) generates vast genomic data, posing challenges for cancer therapy guidance.
  • Human molecular tumor boards (MTBs) manually curate this data, including new therapies and clinical trials, which is time-consuming.
  • The rapid evolution of genomic data interpretation necessitates more efficient analysis methods.

Purpose of the Study:

  • To evaluate the utility of cognitive computing, specifically Watson for Genomics (WfG), in analyzing genomic data compared to traditional human MTBs.
  • To determine if WfG can identify actionable genomic events missed by human curation.
  • To assess the potential of WfG in improving patient care through faster and more comprehensive genomic data analysis.

Main Methods:

  • A retrospective analysis of 1,018 patient cases previously sequenced and analyzed by a human MTB at UNC.
  • Application of Watson for Genomics (WfG), a cognitive computing technology, to the same patient cases for genomic analysis.
  • Comparison of WfG-identified actionable genomic events against those identified by the human MTB.

Main Results:

  • WfG identified additional actionable genomic events in 323 (32%) patients not found by traditional MTB curation.
  • A significant portion of these newly identified events qualified patients for biomarker-selected clinical trials.
  • WfG analysis identified relevant clinical trial opportunities within a month prior to its analysis in nearly a quarter of these patients.
  • Automated WfG analysis was completed in under 3 minutes per case.

Conclusions:

  • The interpretation and actionability of somatic NGS results evolve too rapidly for sole reliance on human curation.
  • Cognitive computing-powered MTBs can enhance patient care by providing rapid, comprehensive genomic data analysis.
  • This approach facilitates timely identification of clinical trial eligibility, advancing precision medicine.
  • WfG offers a potentially faster, cost-effective solution for genomic data interpretation and clinical trial matching.